IOVA

Iovance Biotherapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$3.43

Market Cap

$1.14B

Beta

0.74

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+60.60%

EPS Growth (YoY)+16.15%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-29.55%

Debt / Equity0.07

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for IOVA.